mRNA |
paclitaxel |
CCLE |
pan-cancer |
AAC |
0.24 |
5e-08 |
mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
5e-06 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
1e-05 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
3e-05 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-05 |
mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
5e-05 |
mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
9e-05 |
mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
0.16 |
0.0001 |
mRNA |
Irinotecan |
CCLE |
pan-cancer |
AAC |
0.2 |
0.0001 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0002 |